Passage	passage	O	O	O	O
of	of	O	O	O	O
mannitol	mannitol	CHEMICALS	O	OTHERS	I
into	into	O	O	O	O
the	the	O	O	O	O
brain	brain	O	O	O	O
around	around	O	O	O	O
gliomas	gliomas	O	O	OTHERS	I
:	:	O	O	O	O
a	a	O	O	O	O
potential	potential	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
rebound	rebound	O	O	O	O
phenomenon	phenomenon	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
study	study	O	O	O	O
on	on	O	O	O	O
21	21	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

AIM	aim	O	O	O	O
:	:	O	O	O	O
Widespread	widespread	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
mannitol	mannitol	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
reduce	reduce	O	O	O	O
brain	brain	O	DISEASE	OTHERS	I
edema	edema	O	DISEASE	OTHERS	I
and	and	O	O	O	O
lower	lower	O	O	O	O
elevated	elevated	O	O	OTHERS	I
ICP	icp	O	O	OTHERS	I
in	in	O	O	O	O
brain	brain	O	O	OTHERS	I
tumor	tumor	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
continues	continues	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
afflicted	afflicted	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
so-called	so-called	O	O	O	O
rebound	rebound	O	O	O	O
phenomenon	phenomenon	O	O	O	O
.	.	O	O	O	O

Leakage	leakage	O	O	O	O
of	of	O	O	O	O
mannitol	mannitol	CHEMICALS	O	OTHERS	I
into	into	O	O	O	O
the	the	O	O	O	O
brain	brain	O	O	O	O
parenchyma	parenchyma	O	O	O	O
through	through	O	O	O	O
an	an	O	O	O	O
altered	altered	O	O	O	O
BBB	bbb	O	O	O	O
and	and	O	O	O	O
secondary	secondary	O	O	O	O
reversal	reversal	O	O	O	O
of	of	O	O	O	O
osmotic	osmotic	O	O	O	O
gradient	gradient	O	O	O	O
is	is	O	O	O	O
considered	considered	O	O	O	O
the	the	O	O	O	O
major	major	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
rebound	rebound	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
has	has	O	O	O	O
only	only	O	O	O	O
been	been	O	O	O	O
demonstrated	demonstrated	O	O	O	O
experimentally	experimentally	O	O	O	O
in	in	O	O	O	O
animals	animals	O	O	O	O
.	.	O	O	O	O

As	as	O	O	O	O
a	a	O	O	O	O
contribution	contribution	O	O	O	O
to	to	O	O	O	O
this	this	O	O	O	O
issue	issue	O	O	O	O
we	we	O	O	O	O
decided	decided	O	O	O	O
to	to	O	O	O	O
research	research	O	O	O	O
the	the	O	O	O	O
possible	possible	O	O	O	O
passage	passage	O	O	O	O
of	of	O	O	O	O
mannitol	mannitol	CHEMICALS	O	OTHERS	I
into	into	O	O	O	O
the	the	O	O	O	O
brain	brain	O	O	O	O
after	after	O	O	O	O
administration	administration	O	O	O	O
to	to	O	O	O	O
21	21	O	O	O	O
brain	brain	O	O	OTHERS	I
tumor	tumor	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
Mannitol	mannitol	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
18	18	O	O	O	O
%	%	O	O	O	O
solution	solution	O	O	O	O
;	;	O	O	O	O
1	1	O	O	O	O
g/kg	g/kg	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
administered	administered	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
bolus	bolus	O	O	O	O
to	to	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
ten	ten	O	O	O	O
had	had	O	O	O	O
malignant	malignant	O	O	OTHERS	I
glioma	glioma	O	O	OTHERS	I
,	,	O	O	O	O
seven	seven	O	O	O	O
brain	brain	O	O	O	O
metastases	metastases	O	O	OTHERS	I
and	and	O	O	O	O
four	four	O	O	O	O
meningioma	meningioma	O	O	OTHERS	I
)	)	O	O	O	O
about	about	O	O	O	O
30	30	O	O	O	O
minutes	minutes	O	O	O	O
before	before	O	O	O	O
craniotomy	craniotomy	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
resection	resection	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
sample	sample	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
surrounding	surrounding	O	O	O	O
edematous	edematous	O	O	OTHERS	I
white	white	O	O	O	O
matter	matter	O	O	O	O
was	was	O	O	O	O
taken	taken	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
time	time	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
10	10	O	O	O	O
ml	ml	O	O	O	O
venous	venous	O	O	O	O
blood	blood	O	O	O	O
sample	sample	O	O	O	O
.	.	O	O	O	O

Mannitol	mannitol	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
were	were	O	O	O	O
measured	measured	O	O	O	O
in	in	O	O	O	O
plasma	plasma	O	O	O	O
and	and	O	O	O	O
white	white	O	O	O	O
matter	matter	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
modified	modified	O	O	O	O
version	version	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
enzyme	enzyme	O	O	O	O
assay	assay	O	O	O	O
of	of	O	O	O	O
Blonquist	blonquist	O	O	O	O
et	et	O	O	O	O
al.	al.	O	O	O	O
RESULTS	results	O	O	O	O
:	:	O	O	O	O
In	in	O	O	O	O
most	most	O	O	O	O
glioma	glioma	O	O	OTHERS	I
patients	patients	O	O	O	O
,	,	O	O	O	O
mannitol	mannitol	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
in	in	O	O	O	O
white	white	O	O	O	O
matter	matter	O	O	O	O
were	were	O	O	O	O
2	2	O	O	O	O
to	to	O	O	O	O
6	6	O	O	O	O
times	times	O	O	O	O
higher	higher	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
plasma	plasma	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
3.5	3.5	O	O	O	O
times	times	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
meningioma	meningioma	O	O	OTHERS	I
and	and	O	O	O	O
metastases	metastases	O	O	OTHERS	I
patients	patients	O	O	O	O
plasma	plasma	O	O	O	O
concentrations	concentrations	O	O	O	O
of	of	O	O	O	O
mannitol	mannitol	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
higher	higher	O	O	O	O
than	than	O	O	O	O
white	white	O	O	O	O
matter	matter	O	O	O	O
concentrations	concentrations	O	O	O	O
except	except	O	O	O	O
in	in	O	O	O	O
three	three	O	O	O	O
cases	cases	O	O	O	O
with	with	O	O	O	O
infiltration	infiltration	O	O	O	O
by	by	O	O	O	O
neoplastic	neoplastic	O	O	O	O
cells	cells	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
results	results	O	O	O	O
of	of	O	O	O	O
our	our	O	O	O	O
study	study	O	O	O	O
show	show	O	O	O	O
that	that	O	O	O	O
even	even	O	O	O	O
after	after	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
bolus	bolus	O	O	O	O
,	,	O	O	O	O
mannitol	mannitol	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
leak	leak	O	O	O	O
through	through	O	O	O	O
the	the	O	O	O	O
altered	altered	O	O	O	O
BBB	bbb	O	O	O	O
near	near	O	O	O	O
gliomas	gliomas	O	O	OTHERS	I
,	,	O	O	O	O
reversing	reversing	O	O	O	O
the	the	O	O	O	O
initial	initial	O	O	O	O
plasma-to-blood	plasma-to-blood	O	O	O	O
osmotic	osmotic	O	O	O	O
gradient	gradient	O	O	O	O
,	,	O	O	O	O
aggravating	aggravating	O	O	O	O
peritumoral	peritumoral	O	O	O	O
edema	edema	O	DISEASE	OTHERS	I
and	and	O	O	O	O
promoting	promoting	O	O	O	O
rebound	rebound	O	O	O	O
of	of	O	O	O	O
ICP	icp	O	O	O	O
.	.	O	O	O	O

